Xanthoma (Fatty Skin Nodules)

What is Xanthoma (fatty skin nodules)?

Xanthoma (plural: xanthomas) refers to raised, yellow‑to‑orange skin lesions that are composed of lipid‑laden macrophages (called foam cells) that collect in the dermis. They most commonly appear as soft or firm nodules, papules, or plaques and can develop anywhere on the body, though certain sub‑types favor specific sites (e.g., tendons, eyelids, or the palms). Xanthomas are not a disease themselves; they are a visible sign that something is wrong with the body’s lipid metabolism, an underlying disease, or a medication effect.

The word comes from the Greek xanthos meaning “yellow.” Because the lesions are usually painless and grow slowly, many people discover them incidentally during a routine skin examination or when a family member points them out.

Common Causes

While the hallmark of xanthomas is abnormal lipid storage, a variety of medical conditions or medications can trigger their formation. Below are the most frequent causes, grouped by category.

• Familial Hypercholesterolemia (FH) – An autosomal‑dominant disorder causing very high LDL‑cholesterol from birth; tendinous xanthomas over the Achilles tendon or extensor tendons are classic.
• Familial Dysbetalipoproteinemia (Type III hyperlipoproteinemia) – Elevated remnant lipoproteins produce “palmar” or “tuberous” xanthomas on the hands, elbows, and knees.
• Primary (genetic) Hypertriglyceridemia – Very high triglycerides can lead to eruptive xanthomas—tiny, red‑to‑yellow papules on the buttocks, trunk, and extensor surfaces.
• Secondary Hyperlipidemia – Conditions such as uncontrolled diabetes mellitus, hypothyroidism, nephrotic syndrome, or obesity can raise serum lipids and result in xanthomas.
• Cholesterol‑lowering Medications (Statins, PCSK9 inhibitors) – Rarely – Paradoxical drug‑induced xanthomas have been reported, especially when drugs are stopped abruptly.
• Lipid‑storage diseases – Examples include Niemann‑Pick disease, Gaucher disease, and Fabry disease; these systemic disorders cause widespread foamy macrophage deposits.
• Cholesterol‑rich diets or excess alcohol use – Particularly when combined with underlying metabolic disease, they can precipitate eruptive xanthomas.
• Systemic inflammatory conditions – Certain autoimmune diseases (e.g., systemic lupus erythematosus) can be associated with specific xanthoma types.
• Medication‑related causes – Corticosteroids, estrogen therapy, protease inhibitors (used in HIV), and certain immunosuppressants can raise lipid levels and lead to xanthomas.
• Rare tumors – Xanthogranulomatous inflammation can arise in association with neoplasms, though this is uncommon.

Associated Symptoms

Xanthomas themselves are usually asymptomatic, but the underlying condition that produces them may cause other signs and symptoms:

• Cardiovascular complaints – Chest pain, shortness of breath, or claudication if severe atherosclerosis is present (especially in FH).
• Skin changes – Itching or irritation if lesions become large or develop secondary infection.
• Systemic features of underlying disease:
  • Diabetes: polyuria, polydipsia, fatigue.
  • Hypothyroidism: weight gain, cold intolerance, hair loss.
  • Nephrotic syndrome: swelling (edema), foamy urine.
• Joint pain or tendon tenderness – Tendinous xanthomas can cause discomfort during movement.
• Neurologic symptoms – In lipid‑storage diseases, peripheral neuropathy or developmental delay may be present.

When to See a Doctor

Because xanthomas can be a visual clue to serious metabolic or cardiovascular disease, you should schedule an evaluation promptly if you notice any of the following:

• New yellowish nodules or papules that do not fade after a few weeks.
• Rapid increase in size or number of lesions.
• Any lesion that becomes painful, inflamed, or starts to bleed.
• Family history of high cholesterol, early heart attacks, or known lipid disorders.
• Symptoms of high cholesterol or related disease (e.g., chest pain, unexplained fatigue, swelling, frequent urination).
• History of diabetes, thyroid disease, kidney disease, or recent major changes in diet/alcohol use.

Early assessment helps prevent complications such as premature atherosclerosis, pancreatitis (from very high triglycerides), or organ damage from underlying metabolic diseases.

Diagnosis

Diagnosing a xanthoma involves a combination of visual examination, laboratory testing, and sometimes imaging or biopsy.

1. Clinical Examination

• Dermatologic inspection – size, color, distribution, and consistency.
• Palpation – tendinous vs. eruptive forms feel different (firm vs. soft).
• Assessment for other stigmata of lipid disorders (e.g., corneal arcus).

2. Laboratory Evaluation

• Lipid panel – fasting total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Blood glucose & HbA1c – screen for diabetes.
• Thyroid‑stimulating hormone (TSH) – rule out hypothyroidism.
• Renal function tests (creatinine, urine protein) – evaluate nephrotic syndrome.
• Genetic testing – in cases of suspected familial hypercholesterolemia or dysbetalipoproteinemia (e.g., LDLR, APOB, PCSK9 genes).

3. Imaging (if indicated)

• Ultrasound of tendons – can confirm tendon thickening in tendinous xanthomas.
• Cardiac CT or carotid ultrasound – assess for atherosclerotic plaque when cardiovascular risk is high.

4. Skin Biopsy (rarely needed)

When the diagnosis is uncertain, a punch or excisional biopsy shows collections of lipid‑laden macrophages in the dermis, confirming xanthoma.

Treatment Options

The primary goal is to treat the underlying cause; the skin lesions often regress once lipid levels are controlled. Treatment can be divided into systemic therapy, lesion‑directed procedures, and lifestyle measures.

1. Systemic Medical Therapy

• Statins (e.g., atorvastatin, rosuvastatin) – First‑line for LDL‑cholesterol reduction; can lower lesion size within months.
• Ezetimibe – Inhibits intestinal cholesterol absorption; useful as add‑on therapy.
• PCSK9 inhibitors (evolocumab, alirocumab) – Very effective for familial hypercholesterolemia, can dramatically shrink tendinous xanthomas.
• Fibrates (gemfibrozil, fenofibrate) – Lower triglycerides, helpful for eruptive xanthomas.
• Niacin – Can raise HDL and lower triglycerides, but limited by side effects.
• Omega‑3 fatty acid supplements – Adjunct for triglyceride reduction.
• Therapies for secondary causes – Levothyroxine for hypothyroidism, insulin or oral hypoglycemics for diabetes, ACE inhibitors/diuretics for nephrotic syndrome.

2. Lesion‑Directed Procedures

• Laser therapy (e.g., pulsed‑dye or CO₂ laser) – Useful for superficial or cosmetically bothersome lesions.
• Surgical excision – Considered for large, painful, or infected nodules.
• Cryotherapy – Can flatten small eruptive papules.
• Dermabrasion or chemical peels – Occasionally employed for widespread superficial lesions.

Procedural removal does not replace the need for systemic lipid management; lesions often recur if the lipid abnormality persists.

3. Lifestyle & Home Measures

• Heart‑healthy diet – Emphasize fruits, vegetables, whole grains, lean protein, and limit saturated fats, trans fats, and cholesterol.
• Physical activity – At least 150 minutes of moderate aerobic exercise per week improves lipid profile.
• Weight management – Reducing excess body weight lowers triglycerides and LDL.
• Alcohol moderation – Excess alcohol can spike triglycerides; limit to ≤ 1 drink/day for women, ≤ 2 drinks/day for men.
• Smoking cessation – Smoking accelerates atherosclerosis and may worsen lipid abnormalities.
• Medication adherence – Never stop statins or other lipid‑lowering drugs without a physician’s guidance.

Prevention Tips

While genetic forms cannot be “prevented,” many risk factors are modifiable:

• Screen family members early if a hereditary lipid disorder is known; start lifestyle changes in childhood.
• Maintain regular lipid checks (every 4–6 years for adults without risk factors, more often if abnormal).
• Follow a Mediterranean‑style diet rich in omega‑3 fatty acids (e.g., fatty fish, flaxseed).
• Control blood pressure and blood glucose to reduce secondary hyperlipidemia.
• Limit intake of sugary foods and refined carbohydrates, which raise triglycerides.
• Stay current on vaccinations and treat infections promptly; some infections can transiently raise lipids.
• If on medications known to alter lipids, discuss monitoring plans with your provider.

Emergency Warning Signs

If any of the following occurs, seek immediate medical attention (call 911 or go to the nearest emergency department):

• Severe, sudden chest pain or pressure radiating to the arm, neck, or jaw – possible heart attack.
• Sudden onset of intense abdominal pain, especially with vomiting – could indicate pancreatitis from extremely high triglycerides.
• Rapid swelling of the face, lips, or tongue accompanied by difficulty breathing – rare but possible anaphylactic reaction to a medication used for lipid control.
• Rapidly enlarging, extremely painful, or infected skin nodules with fever – may require urgent drainage and antibiotics.

---

**References**

• Mayo Clinic. “Xanthoma.” mayoclinic.org. Accessed April 2026.
• American Heart Association. “Familial Hypercholesterolemia.” heart.org.
• National Institute of Diabetes and Digestive and Kidney Diseases. “Lipid Disorders.” niddk.nih.gov.
• Cleveland Clinic. “Eruptive Xanthoma.” clevelandclinic.org.
• World Health Organization. “WHO Guidelines on Dietary Fats and Cardiovascular Disease.” 2022.
• J. G. H. Watts et al., “Management of Familial Hypercholesterolemia in Adults,” JAMA Cardiology, 2021.